Strategic Board Growth Cerebriu recently expanded its leadership with a new board member in March 2026, signaling an emphasis on governance, strategic partnerships, and potential investor confidence. This presents an opportunity to engage at the executive level around scaling, governance, and procurement for enterprise-grade radiology AI deployments.

Global Expansion Financing With a capital raise of €17.4 million ($19.4M) in 2024 to expand MRI AI accessibility worldwide, there is a clear push into new markets and hospital networks. Sales opportunities include multi-region deployments, channel partnerships, and enterprise contracts with large radiology groups and hospital systems seeking scalable AI-driven workflow optimization.

Integrated AI Ecosystem Cerebriu has a history of integrations with other radiology AI platforms and marketplaces (e.g., Carpl.ai and HeartVista). This points to a buyer preference for interoperable solutions and co-deployed technology stacks, suggesting a path for joint integrations, OEM partnerships, or marketplace-enabled licensing to broaden adoption.

Real-time MRI Advantage Apollo and Smart Reading enable real-time triage and protocol optimization in brain MRI, addressing clinician time, workflow efficiency, and patient experience. Target opportunities include radiology departments prioritizing throughput, reduced recalls, and improved technologist confidence in scanner operation across hospital networks.

Clinical Advisory Endorsements Engagement by clinical experts, including a named clinical advisor and a track record of CE-marked solutions, strengthens credibility for adoption in regulated markets. Focus sales on hospital procurement with emphasis on regulatory compliance, clinical validation, and documented ROI in workflow time savings and diagnostic throughput.